Amazon starts drug subscription service for Prime members

0

By Matt Day | Bloomberg

Amazon.com Inc. has started a $5-per-month drug subscription service for Prime members, the e-commerce giant’s latest foray into health care.

Called RxPass, the service lets patients order generic medications that treat more than 80 common health conditions, the company said in a statement Tuesday. Customers need to be members of Amazon’s $139-a-year Prime service to join and will be entitled to free delivery.

RxPass is available in most US states but for now excludes a number of heavily populated ones, including California, Pennsylvania and Texas. The program’s web page lists a menu of 53 available medications.

“We are excited to offer our customers surprisingly simple, low pricing on the eligible medications they need each month,” said John Love, vice president of Amazon Pharmacy.

Amazon for years has been trying to break into the health care industry. It purchased mail-order pharmacy PillPack Inc. in 2018 and joined a much ballyhooed health care venture with JPMorgan Chase & Co. and Berkshire Hathaway Inc. that fizzled out after three years.

The company also developed a telehealth and home health service, called Amazon Care, that wound down after operating for a little more than a year. Amazon is now trying to purchase the parent of the One Medical line of medical clinics for $3.49 billion.

More stories like this are available on bloomberg.com

©2023 Bloomberg L.P.

Stay connected with us on social media platform for instant update click here to join our  Twitter, & Facebook

We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.

For all the latest  Business News Click Here 

Read original article here

Denial of responsibility! Rapidtelecast.com is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.
Leave a comment